These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2119889)

  • 21. Promoter trans-activation of protooncogenes c-fos and c-myc, but not c-Ha-ras, by products of adenovirus early region 1A.
    Sassone-Corsi P; Borrelli E
    Proc Natl Acad Sci U S A; 1987 Sep; 84(18):6430-3. PubMed ID: 2957694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Roles of JAK kinase in human GM-CSF receptor signals.
    Watanabe S; Itoh T; Arai K
    Leukemia; 1997 Apr; 11 Suppl 3():76-8. PubMed ID: 9209304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IP-1: a dominant inhibitor of Fos/Jun whose activity is modulated by phosphorylation.
    Auwerx J; Sassone-Corsi P
    Cell; 1991 Mar; 64(5):983-93. PubMed ID: 1900458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reconstitution of signal transduction from the membrane to the nucleus in a baculovirus expression system: activation of Raf-1 leads to hypermodification of c-jun and c-fos via multiple pathways.
    Agarwal S; Corbley MJ; Roberts TM
    Oncogene; 1995 Aug; 11(3):427-38. PubMed ID: 7543194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The v- and c-myc oncogene proteins colocalize in situ with small nuclear ribonucleoprotein particles.
    Spector DL; Watt RA; Sullivan NF
    Oncogene; 1987 Mar; 1(1):5-12. PubMed ID: 2963988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lesion-induced increase in nerve growth factor mRNA is mediated by c-fos.
    Hengerer B; Lindholm D; Heumann R; Rüther U; Wagner EF; Thoenen H
    Proc Natl Acad Sci U S A; 1990 May; 87(10):3899-903. PubMed ID: 2111020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The transcription factors CREB and c-Fos play key roles in NCAM-mediated neuritogenesis in PC12-E2 cells.
    Jessen U; Novitskaya V; Pedersen N; Serup P; Berezin V; Bock E
    J Neurochem; 2001 Dec; 79(6):1149-60. PubMed ID: 11752056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transformation of T lymphocytes by the v-fos oncogene.
    Valge-Archer VE; de Villiers J; Sinskey AJ; Rao A
    J Immunol; 1990 Dec; 145(12):4355-64. PubMed ID: 2124241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. E1A-dependent trans-activation of the c-fos promoter requires the TATAA sequence.
    Simon MC; Rooney RJ; Fisch TM; Heintz N; Nevins JR
    Proc Natl Acad Sci U S A; 1990 Jan; 87(2):513-7. PubMed ID: 2137244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microphthalmia-associated transcription factor interacts with PU.1 and c-Fos: determination of their subcellular localization.
    Sato M; Morii E; Takebayashi-Suzuki K; Yasui N; Ochi T; Kitamura Y; Nomura S
    Biochem Biophys Res Commun; 1999 Jan; 254(2):384-7. PubMed ID: 9918847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A naturally occurring truncated form of FosB that inhibits Fos/Jun transcriptional activity.
    Nakabeppu Y; Nathans D
    Cell; 1991 Feb; 64(4):751-9. PubMed ID: 1900040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential regulation and expression of jun, c-fos and c-myc proto-oncogenes during mouse liver regeneration and after inhibition of protein synthesis.
    Morello D; Lavenu A; Babinet C
    Oncogene; 1990 Oct; 5(10):1511-9. PubMed ID: 2123531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transactivation of c-fos and beta-actin genes by raf as a step in early response to transmembrane signals.
    Jamal S; Ziff E
    Nature; 1990 Mar; 344(6265):463-6. PubMed ID: 2157161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell-type specific multiprotein complex formation over the c-fos serum response element in vivo: ternary complex formation is not required for the induction of c-fos.
    König H
    Nucleic Acids Res; 1991 Jul; 19(13):3607-11. PubMed ID: 1906604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CSF-1 induces fos gene transcription and activates the transcription factor Elk-1 in mature osteoclasts.
    Yao GQ; Itokawa T; Paliwal I; Insogna K
    Calcif Tissue Int; 2005 May; 76(5):371-8. PubMed ID: 15812575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Translocation of Akt/PKB to the nucleus of osteoblast-like MC3T3-E1 cells exposed to proliferative growth factors.
    Borgatti P; Martelli AM; Bellacosa A; Casto R; Massari L; Capitani S; Neri LM
    FEBS Lett; 2000 Jul; 477(1-2):27-32. PubMed ID: 10899305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trans-dominant negative mutants of Fos and Jun.
    Ransone LJ; Visvader J; Wamsley P; Verma IM
    Proc Natl Acad Sci U S A; 1990 May; 87(10):3806-10. PubMed ID: 2111017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of resistance factors (P-glycoprotein, glutathione S-transferase-pi, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomas.
    Volm M; Kästel M; Mattern J; Efferth T
    Cancer; 1993 Jun; 71(12):3981-7. PubMed ID: 8099529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of revertant cell lines to identify targets of v-fos transformation-specific alterations in gene expression.
    Hoemann CD; Zarbl H
    Cell Growth Differ; 1990 Dec; 1(12):581-90. PubMed ID: 2126949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrin-mediated adhesion of endothelial cells induces JAK2 and STAT5A activation: role in the control of c-fos gene expression.
    Brizzi MF; Defilippi P; Rosso A; Venturino M; Garbarino G; Miyajima A; Silengo L; Tarone G; Pegoraro L
    Mol Biol Cell; 1999 Oct; 10(10):3463-71. PubMed ID: 10512880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.